Gene · 1879
EBF1: EBF transcription factor 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. EBF1: EBF transcription factor 1. Genes, record 1879. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1879
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UH73 | Transcription factor COE1 | 591 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents43
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4805378 A1 | 2026-09-16 | 630 | Q9UH73 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 5460 | Q9UH73 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 5071 | Q9UH73 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14913 | Q9UH73 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 5071 | Q9UH73 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 5460 | Q9UH73 | Espacenet |
| JP 2025511192 A | 2025-04-15 | 24 | Q9UH73 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 27606 | Q9UH73 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14913 | Q9UH73 | Espacenet |
| EP 4504225 A2 | 2025-02-12 | 24 | Q9UH73 | Espacenet |
1 to 10 of 43
See all 43 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,659
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | EBF1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA021765 | Cancer Center Support Grant (CCSG) | 28 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 16 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 10 | 2025 |
| R01CA157644 | Central tolerance mechanisms in B-cell malignancies | 10 | 2025 |
| R01DE017336 | Epigenetic Regulation of Epstein-Barr Virus | 9 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 8 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 8 | 2025 |
| R35CA197695 | Translating genomic discoveries to improved outcomes for high risk acute leukemia | 8 | 2025 |
| T32AI007405 | Training Program in Immunology | 8 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
1 to 10 of 2,659Source NIH's project files
See all 2,659 nih grantsPapers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HIV-1 Vpr Drives a B Cell-Like Phenotype in Primary CD4+ T Cells. | MedComm (2020) | 2026 | 42802798 | PubTator, text mining | PubMed |
| Integrated metabolomics and DNA methylation signatures and their association with flare remission in SLE. | Lupus Sci Med | 2026 | 42731887 | PubTator, text mining | PubMed |
| Intrinsic and non-cell-autonomous roles for the neurodevelopmental syndrome-linked transcription factor UNC-3/EBF. | Nat Commun | 2026 | 42711312 | PubTator, text mining | PubMed |
| Oncogenic Mutations and Tumor Microenvironment Alterations in Diffuse Large B-Cell Lymphoma With Bulky Disease. | Cancer Med | 2026 | 42702822 | PubTator, text mining | PubMed |
| LATS1/2 inactivation drives a distinct venous endothelial cell response that contributes to fibrotic remodeling of the lung. | Sci Adv | 2026 | 42664350 | PubTator, text mining | PubMed |
| Unraveling the pathogenic mechanisms of osteoarthritis and obesity: An integration of GWAS, cellular specificity, and spatial transcriptomics. | Osteoarthr Cartil Open | 2026 | 42656980 | PubTator, text mining | PubMed |
| Pediatric B-Cell Acute Lymphoblastic Leukemia: Comprehensive Genomic Characterization Including SNP-Array and Analysis of Relapse Risk. | Cancers (Basel) | 2026 | 42649943 | PubTator, text mining | PubMed |
| Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia. | Br J Haematol | 2026 | 42575717 | PubTator, text mining | PubMed |
| Gene regulatory network approach to decipher key transcriptional dynamics driving differentiation of induced pluripotent stem cells to neural lineage. | Comput Biol Chem | 2026 | 42546633 | PubTator, text mining | PubMed |
| EBF1: A Multidimensional Role Integrating Metabolism and Metabolic Diseases. | Curr Top Med Chem | 2026 | 42517394 | PubTator, text mining | PubMed |
1 to 10 of 2,714
See all 2,714 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1879
GET https://conductscience.org/api/genes/v1/1879/patents?page=2